Stay updated on Durvalumab vs Placebo in Early NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.

Latest updates to the Durvalumab vs Placebo in Early NSCLC Clinical Trial page
- Check3 days agoChange DetectedRecruitment status has been updated to 'no longer looking for participants,' indicating the trial is no longer actively seeking enrollees. The revision history also shows a new release labeled v3.6.0 and the prior v3.5.5 entry has been removed from the log.SummaryDifference0.2%

- Check10 days agoChange DetectedThe page history shows a new Revision: v3.5.5 replacing the previous v3.5.4, reflecting an update to the record history interface.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision label v3.5.4 was added and the previous v3.5.3 revision was removed from the page history.SummaryDifference0.1%

- Check53 days agoChange DetectedThe record history view was updated to include a newer submitted/revision entry (and corresponding UI revision version). This indicates an additional study history update affecting sections like Contacts/Locations and Study Status, rather than a major change to the core study description or outcomes.SummaryDifference0.3%

- Check60 days agoChange DetectedRevision history shows an update from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.1%

Stay in the know with updates to Durvalumab vs Placebo in Early NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.